Legal & General Group PLC Morphic Holding, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 29,214 shares of MORF stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,214

Previous 29,399 0.63%

Holding current value

$1.66 Million

Previous $1.03 Million 3.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $4,832 - $6,302	-185 Reduced 0.63%	29,214 $995,000
Q1 2024 May 14, 2024	BUY	$26.64 - $40.31 $13,826 - $20,920	519 Added 1.8%	29,399 $1.03 Million
Q4 2023 Feb 15, 2024	BUY	$19.95 - $31.0 $3,551 - $5,518	178 Added 0.62%	28,880 $834,000
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $56,097 - $156,274	2,630 Added 10.09%	28,702 $657,000
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $588,107 - $1.06 Million	17,131 Added 191.6%	26,072 $1.49 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $12,198 - $22,835	469 Added 5.54%	8,941 $336,000
Q4 2022 Feb 14, 2023	BUY	$24.14 - $30.37 $7,459 - $9,384	309 Added 3.79%	8,472 $226,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $11,893 - $17,852	535 Added 7.01%	8,163 $231,000
Q2 2022 Aug 22, 2022	BUY	$19.74 - $43.01 $1,085 - $2,365	55 Added 0.73%	7,628 $165,000
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $6,235 - $8,947	172 Added 2.32%	7,573 $304,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $2,293 - $3,483	53 Added 0.72%	7,401 $350,000
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $188,868 - $237,802	3,523 Added 92.1%	7,348 $416,000
Q2 2021 Aug 12, 2021	BUY	$45.13 - $64.99 $52,260 - $75,258	1,158 Added 43.42%	3,825 $220,000
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $7,948 - $22,654	267 Added 11.13%	2,667 $169,000
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $18,475 - $24,875	720 Added 42.86%	2,400 $80,000
Q3 2020 Nov 13, 2020	SELL	$22.51 - $30.11 $13,033 - $17,433	-579 Reduced 25.63%	1,680 $46,000
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $8,184 - $19,131	647 Added 40.14%	2,259 $61,000
Q1 2020 May 14, 2020	BUY	$10.84 - $20.85 $6,720 - $12,927	620 Added 62.5%	1,612 $24,000
Q4 2019 Feb 13, 2020	BUY	$13.02 - $19.5 $2,369 - $3,549	182 Added 22.47%	992 $17,000
Q3 2019 Nov 13, 2019	BUY	$17.46 - $29.05 $14,142 - $23,530	810 New	810 $15,000

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Morphic Holding, Inc. Transaction History